Erythropoietin or darbepoetin for patients with cancer

Author:

Tonia Thomy1,Mettler Annette1,Robert Nadège2,Schwarzer Guido3,Seidenfeld Jerome4,Weingart Olaf5,Hyde Chris6,Engert Andreas7,Bohlius Julia1

Affiliation:

1. University of Bern; Institute of Social and Preventive Medicine; Bern Switzerland 3012

2. Kantonsspitalapotheke Winterthur; Pharmacy; Brauerstrasse 15 Winterthur Switzerland CH-8400

3. Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg; German Cochrane Centre; Stefan-Meier-Str. 26 Freiburg Germany D-79104

4. American Society of Clinical Oncology; Department of Quality and Guidelines; 1900 Duke Street, Suite 200 Alexandria VA USA 22314

5. Achterstreet 11 Cologne Germany 50678

6. University of Exeter Medical School, University of Exeter; Peninsula Technology Assessment Group (PenTAG); Veysey Building Salmon Pool Lane Exeter UK EX2 4SG

7. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

Publisher

Wiley

Subject

Pharmacology (medical)

Reference692 articles.

1. Aapro M Barnadas A Leonard RC Marangolo M Untch M Effects of epoetin beta treatment in patients with metastatic breast cancer receiving chemotherapy. Results of the BRAVE trial Breast Cancer Research and Treatment 2006 abstract 6095

2. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) Study;Aapro;Journal of Clinical Oncology,2008

3. Once weekly epoetin beta in patients with metastatic breast cancer receiving anthracycline- or taxane-based chemotherapy;Leonard;Annals of Oncology,2004

4. Erythropoietin or darbepoetin for patients with cancer - meta-analysis based on individual patient data;Bohlius;Cochrane Database of Systematic Reviews,2009

5. Erythropoietin for anemia in cancer patients;Abels;European Journal of Cancer,1993

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3